Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib

Recent efforts to personalize treatment with platinum-based chemotherapy and PARP inhibitors have produced promising results in homologous recombinant deficient (HRD) metastatic pancreatic cancer (MPC). However, new strategies are necessary to overcome resistance. The below case series documents pat...

詳細記述

書誌詳細

主要な著者:	Gehan Botrus, Denise Roe, Gayle S. Jameson, Pedro Luiz Serrano Uson Junior, Ronald Lee Korn, Lana Caldwell, Taylor Bargenquast, Max Miller, Erkut Hasan Borazanci
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-10-01
シリーズ:	Biomedicines
主題:	pancreatic cancer BRCA Olaparib homologous recombination deficient mitomycin
オンライン･アクセス:	https://www.mdpi.com/2227-9059/10/11/2705
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!